Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 48,839 | 11,379 | 35,029 | 26,856 | 8,881 |
| Marketable Securities | N/A | N/A | N/A | 1,555 | N/A |
| TOTAL | $49,193 | $11,706 | $35,528 | $28,873 | $9,093 |
| Non-Current Assets | |||||
| PPE Net | 255 | 489 | 746 | 451 | 270 |
| Other Non-Current Assets | 288 | 378 | 453 | 188 | 130 |
| TOTAL | $543 | $867 | $1,199 | $639 | $400 |
| Total Assets | $49,736 | $12,573 | $36,727 | $29,512 | $9,492 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,789 | 2,639 | 2,909 | 776 | 836 |
| Accrued Expenses | 1,261 | 3,137 | 3,397 | 2,162 | 1,419 |
| TOTAL | $3,095 | $5,776 | $6,306 | $2,938 | $2,255 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 45 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 18,471 | 0 | 0 | 0 | 0 |
| TOTAL | $18,537 | $58 | $51 | $41 | $36 |
| Total Liabilities | $21,632 | $5,834 | $6,357 | $2,979 | $2,290 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 277 | 146 | 142 | 102 | 49 |
| Common Shares | 42 | 22 | 21 | 15 | 7 |
| Retained earnings | -91,144 | -85,061 | -59,829 | -33,221 | -15,364 |
| TOTAL | $28,104 | $6,739 | $30,370 | $26,533 | $7,202 |
| Total Liabilities And Equity | $49,736 | $12,573 | $36,727 | $29,512 | $9,492 |